ID   PGS2_RAT                Reviewed;         354 AA.
AC   Q01129;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1993, sequence version 1.
DT   24-JUL-2024, entry version 178.
DE   RecName: Full=Decorin;
DE   AltName: Full=Bone proteoglycan II;
DE   AltName: Full=Dermatan sulfate proteoglycan-II;
DE            Short=DSPG;
DE   AltName: Full=PG-S2;
DE   AltName: Full=PG40;
DE   Flags: Precursor;
GN   Name=Dcn;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Sprague-Dawley; TISSUE=Uterus;
RX   PubMed=1390895; DOI=10.1016/0167-4781(92)90019-v;
RA   Abramson S.R., Woessner J.F.;
RT   "cDNA sequence for rat dermatan sulfate proteoglycan-II (decorin).";
RL   Biochim. Biophys. Acta 1132:225-227(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 11-354.
RX   PubMed=1493796;
RA   Asundi V.K., Dreher K.L.;
RT   "Molecular characterization of vascular smooth muscle decorin: deduced core
RT   protein structure and regulation of gene expression.";
RL   Eur. J. Cell Biol. 59:314-321(1992).
RN   [4]
RP   PROTEIN SEQUENCE OF 31-48 AND 171-191, AND GLYCOSYLATION AT SER-34.
RC   STRAIN=Sprague-Dawley; TISSUE=Uterus;
RX   PubMed=2764879; DOI=10.1042/bj2600413;
RA   Kokenyesi R., Woessner J.F.;
RT   "Purification and characterization of a small dermatan sulphate
RT   proteoglycan implicated in the dilatation of the rat uterine cervix.";
RL   Biochem. J. 260:413-419(1989).
RN   [5]
RP   CLEAVAGE OF SIGNAL PEPTIDE AFTER ALA-16, CLEAVAGE OF PROPEPTIDE AFTER
RP   GLU-30, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=26479776; DOI=10.1021/acs.jproteome.5b00820;
RA   Tsuchiya T., Osaki T., Minamino N., Sasaki K.;
RT   "Peptidomics for studying limited proteolysis.";
RL   J. Proteome Res. 14:4921-4931(2015).
CC   -!- FUNCTION: May affect the rate of fibrils formation (By similarity). May
CC       be implicated in the dilatation of the rat cervix. {ECO:0000250}.
CC   -!- SUBUNIT: Binds to type I and type II collagen, fibronectin and TGF-
CC       beta. Forms a ternary complex with MFAP2 and ELN. Interacts with DPT
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular
CC       matrix. Secreted {ECO:0000250|UniProtKB:P07585}.
CC   -!- DEVELOPMENTAL STAGE: The amount of DSPG per cervix increases 4-fold
CC       during pregnancy, then falls precipitously within 1 day post partum.
CC   -!- PTM: The attached glycosaminoglycan chain can be either chondroitin
CC       sulfate or dermatan sulfate depending upon the tissue of origin.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the small leucine-rich proteoglycan (SLRP)
CC       family. SLRP class I subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z12298; CAA78170.1; -; mRNA.
DR   EMBL; BC083750; AAH83750.1; -; mRNA.
DR   EMBL; X59859; CAA42519.1; -; mRNA.
DR   PIR; S29145; S29145.
DR   RefSeq; NP_077043.1; NM_024129.1.
DR   RefSeq; XP_006241347.1; XM_006241285.1.
DR   AlphaFoldDB; Q01129; -.
DR   SMR; Q01129; -.
DR   BioGRID; 247822; 4.
DR   IntAct; Q01129; 1.
DR   STRING; 10116.ENSRNOP00000006070; -.
DR   GlyCosmos; Q01129; 5 sites, No reported glycans.
DR   GlyGen; Q01129; 5 sites.
DR   iPTMnet; Q01129; -.
DR   PhosphoSitePlus; Q01129; -.
DR   SwissPalm; Q01129; -.
DR   PaxDb; 10116-ENSRNOP00000006070; -.
DR   Ensembl; ENSRNOT00000006070.7; ENSRNOP00000006070.4; ENSRNOG00000004554.7.
DR   Ensembl; ENSRNOT00055009516; ENSRNOP00055007329; ENSRNOG00055005884.
DR   Ensembl; ENSRNOT00060008866; ENSRNOP00060006692; ENSRNOG00060005312.
DR   Ensembl; ENSRNOT00065019740; ENSRNOP00065015121; ENSRNOG00065012130.
DR   GeneID; 29139; -.
DR   KEGG; rno:29139; -.
DR   UCSC; RGD:61895; rat.
DR   AGR; RGD:61895; -.
DR   CTD; 1634; -.
DR   RGD; 61895; Dcn.
DR   eggNOG; KOG0619; Eukaryota.
DR   GeneTree; ENSGT00940000158382; -.
DR   HOGENOM; CLU_000288_186_0_1; -.
DR   InParanoid; Q01129; -.
DR   OrthoDB; 3953748at2759; -.
DR   PhylomeDB; Q01129; -.
DR   TreeFam; TF334562; -.
DR   Reactome; R-RNO-1474228; Degradation of the extracellular matrix.
DR   Reactome; R-RNO-1971475; A tetrasaccharide linker sequence is required for GAG synthesis.
DR   Reactome; R-RNO-2022870; Chondroitin sulfate biosynthesis.
DR   Reactome; R-RNO-2022923; Dermatan sulfate biosynthesis.
DR   Reactome; R-RNO-2024101; CS/DS degradation.
DR   Reactome; R-RNO-3000178; ECM proteoglycans.
DR   PRO; PR:Q01129; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000004554; Expressed in stomach and 20 other cell types or tissues.
DR   GO; GO:0005589; C:collagen type VI trimer; IDA:RGD.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005518; F:collagen binding; IDA:RGD.
DR   GO; GO:0050840; F:extracellular matrix binding; ISO:RGD.
DR   GO; GO:0005539; F:glycosaminoglycan binding; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; IEP:RGD.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; ISO:RGD.
DR   GO; GO:0010596; P:negative regulation of endothelial cell migration; ISO:RGD.
DR   GO; GO:1900747; P:negative regulation of vascular endothelial growth factor signaling pathway; ISO:RGD.
DR   GO; GO:0001890; P:placenta development; IEP:RGD.
DR   GO; GO:0010508; P:positive regulation of autophagy; ISO:RGD.
DR   GO; GO:0016239; P:positive regulation of macroautophagy; ISO:RGD.
DR   GO; GO:0051901; P:positive regulation of mitochondrial depolarization; ISO:RGD.
DR   GO; GO:0090141; P:positive regulation of mitochondrial fission; ISO:RGD.
DR   GO; GO:0051897; P:positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transduction; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IEP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEP:RGD.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEP:RGD.
DR   Gene3D; 3.80.10.10; Ribonuclease Inhibitor; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR000372; LRRNT.
DR   InterPro; IPR050333; SLRP.
DR   InterPro; IPR016352; SLRP_I_decor/aspor/byglycan.
DR   PANTHER; PTHR45712; AGAP008170-PA; 1.
DR   PANTHER; PTHR45712:SF14; DECORIN; 1.
DR   Pfam; PF13855; LRR_8; 3.
DR   Pfam; PF01462; LRRNT; 1.
DR   PIRSF; PIRSF002490; SLRP_I; 1.
DR   SMART; SM00364; LRR_BAC; 3.
DR   SMART; SM00369; LRR_TYP; 7.
DR   SMART; SM00013; LRRNT; 1.
DR   SUPFAM; SSF52058; L domain-like; 1.
DR   PROSITE; PS51450; LRR; 8.
PE   1: Evidence at protein level;
KW   Direct protein sequencing; Disulfide bond; Extracellular matrix;
KW   Glycoprotein; Leucine-rich repeat; Proteoglycan; Reference proteome;
KW   Repeat; Secreted; Signal.
FT   SIGNAL          1..16
FT                   /evidence="ECO:0000269|PubMed:26479776"
FT   PROPEP          17..30
FT                   /evidence="ECO:0000269|PubMed:26479776,
FT                   ECO:0000269|PubMed:2764879"
FT                   /id="PRO_0000032719"
FT   CHAIN           31..354
FT                   /note="Decorin"
FT                   /id="PRO_0000032720"
FT   REPEAT          68..88
FT                   /note="LRR 1"
FT   REPEAT          89..112
FT                   /note="LRR 2"
FT   REPEAT          113..136
FT                   /note="LRR 3"
FT   REPEAT          137..157
FT                   /note="LRR 4"
FT   REPEAT          158..181
FT                   /note="LRR 5"
FT   REPEAT          182..207
FT                   /note="LRR 6"
FT   REPEAT          208..228
FT                   /note="LRR 7"
FT   REPEAT          229..252
FT                   /note="LRR 8"
FT   REPEAT          253..276
FT                   /note="LRR 9"
FT   REPEAT          277..299
FT                   /note="LRR 10"
FT   REPEAT          300..329
FT                   /note="LRR 11"
FT   REPEAT          330..354
FT                   /note="LRR 12"
FT   CARBOHYD        34
FT                   /note="O-linked (Xyl...) (glycosaminoglycan) serine"
FT                   /evidence="ECO:0000269|PubMed:2764879"
FT   CARBOHYD        206
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        241
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        257
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        298
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        49..55
FT                   /evidence="ECO:0000250"
FT   DISULFID        53..62
FT                   /evidence="ECO:0000250"
FT   DISULFID        308..341
FT                   /evidence="ECO:0000250"
SQ   SEQUENCE   354 AA;  39805 MW;  152D92F42D9F5A5B CRC64;
     MKATLVLFLL AQVSWAGPFE QRGLFDFMLE DEASGIIPYD PDNPLISMCP YRCQCHLRVV
     QCSDLGLDKV PWEFPPDTTL LDLQNNKITE IKEGAFKNLK DLHTLILVNN KISKISPEAF
     KPLVKLERLY LSKNHLKELP EKLPKTLQEL RLHDNEITKL KKSVFNGLNR MIVIELGGNP
     LKNSGIENGA LQGMKGLGYI RISDTNITAI PQGLPTSISE LHLDGNKIAK VDAASLKGMS
     NLSKLGLSFN SITVVENGSL ANVPHLRELH LDNNKLLRVP AGLAQHKYVQ VVYLHNNNIS
     EVGQHDFCLP SYQTRKTSYT AVSLYSNPVR YWQIHPHTFR CVFGRSTIQL GNYK
//
